4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-002571
Senior Vice President sold 38,750 shares at an average $72.51 ($2,809,578)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hamilton James C Senior Vice President | 2021-01-05 | Sale | −3,800 | $71.09 | $270,142 | 171,200 | D: show line 1 in the form |
| Hamilton James C Senior Vice President | 2021-01-05 | Sale | −3,300 | $72.19 | $238,227 | 167,900 | D: show line 2 in the form |
| Hamilton James C Senior Vice President | 2021-01-05 | Sale | −10,350 | $72.91 | $754,619 | 157,550 | D: show line 3 in the form |
| Hamilton James C Senior Vice President | 2021-01-05 | Sale | −1,925 | $73.93 | $142,315 | 155,625 | D: show line 4 in the form |
| Hamilton James C Senior Vice President | 2021-01-06 | Sale | −700 | $70.89 | $49,623 | 154,925 | D: show line 5 in the form |
| Hamilton James C Senior Vice President | 2021-01-06 | Sale | −3,967 | $72.05 | $285,822 | 150,958 | D: show line 6 in the form |
| Hamilton James C Senior Vice President | 2021-01-06 | Sale | −14,708 | $72.67 | $1,068,830 | 136,250 | D: show line 7 in the form |
| Open-market sales · 38,750 sh · avg $72.51 · $2,809,578 | |||||||
Loading xslF345X03/doc4.xml…